Skip to main content

Table 4. Summary of validation parameter by proposed method

From: A new RP–HPLC method for simultaneous quantification of perindopril erbumine, indapamide, and amlodipine besylate in bulk and pharmaceutical dosage form

Parameters

Perindopril erbumine

Indapamide

Amlodipine besylate

Retention time

3.5 ± 0.2

9.6 ± 0.3

7.1 ± 0.2

Precision

 Repeatability (%RSD)

  Injection (n=6)

1.04

0.61

0.48

 Intermediate (%RSD)

  Intraday (n=3)

0.51 - 0.77

0.62-1.00

0.77-0.93

  Interday (n=3)

0.90-1.58

1.05-1.34

1.18-1.44

Accuracy (% Recovery)

99.52-100.71

99.49-100.89

99.90-100.78

Robustness

Robust

Robust

Robust

Specificity

Specific

specific

Specific